BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Beckman Laser Institute - ECPv6.18.2//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Beckman Laser Institute
X-ORIGINAL-URL:https://bli.uci.edu
X-WR-CALDESC:Events for Beckman Laser Institute
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:UTC
BEGIN:STANDARD
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
TZNAME:UTC
DTSTART:20180101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=UTC:20190808T120000
DTEND;TZID=UTC:20190808T130000
DTSTAMP:20190711T015324Z
CREATED:20190711T015248Z
LAST-MODIFIED:20190711T015324Z
UID:27268-1565265600-1565269200@bli.uci.edu
SUMMARY:Lida Hariri\, MD\, PhD
DESCRIPTION:Assistant Professor\,  Department of Pathology\nDivision of Pulmonary and Critical Care Medicine\nMassachusetts General Hospital\, Harvard Medical School \nIn Vivo Optical Coherence Tomography for Early Detection and Diagnosis of Pulmonary Disease \nAbstract\nIn vivo optical imaging provides microscopic images in patients\, in real time\, without tissue removal. Due to its high resolution\, optical imaging has close parallels with traditional microscopy and can complement and enhance patient care\, including in vivo disease detection\, biopsy guidance\, diagnosis\, and resection margin assessment\, in a variety of organ systems and disease types. In this talk\, I will discuss applications of optical coherence tomography for early detection and diagnosis of pulmonary diseases\, particularly lung cancer and interstitial lung disease\, and real-time tumor biopsy guidance to increase diagnostic yield. \nBiography\nLida Hariri\, MD\, PhD\, is an Assistant Professor of Pathology and biomedical optics researcher at Massachusetts General Hospital. She obtained her MD/PhD at the University of Arizona in 2009\, with her doctorate in Biomedical Engineering focused on multimodal optical imaging for early cancer detection. She subsequently completed her pathology residency training\, and pulmonary and gynecologic pathology fellowships at MGH. Her research interests focus on development\, translation and clinical application of high-resolution optical imaging for: 1) early detection and diagnosis of pulmonary diseases\, particularly lung cancer and interstitial lung disease\, 2) real-time tumor biopsy guidance to increase diagnostic yield\, and 3) integrating in vivo optical microscopy into the practice of clinical medicine and pathology. She is a Vice-Chair of the College of American Pathologists (CAP) In Vivo Microscopy Committee.   \nFor more information or to schedule a meeting with the speaker\, please contact Hanna Kim.
URL:https://bli.uci.edu/event/lida-hariri-phd/
LOCATION:3201 Natural Sciences II
ATTACH;FMTTYPE=image/jpeg:https://bli.uci.edu/wp-content/uploads/2019/07/Hariri_Lida_192.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20190812T120000
DTEND;TZID=UTC:20190812T130000
DTSTAMP:20190724T062446Z
CREATED:20190724T062243Z
LAST-MODIFIED:20190724T062446Z
UID:27290-1565611200-1565614800@bli.uci.edu
SUMMARY:Thomas O’Sullivan\, PhD
DESCRIPTION:Assistant Professor\, Department of Electrical Engineering\, University of Notre Dame \nFast-Changing Times: Advanced Optical Technologies Enabling the Next Generation of Quantitative Diffuse Optical Spectroscopy \nAbstract\nQuantitative Noninvasive Diffuse Optical Spectroscopy utilizing time-dependent methods can separate the effects of optical absorption and scattering and thus provide greater accuracy\, precision\, and 3D resolution of deep tissue physiology compared to continuous-wave methods.  Unfortunately\, despite 30 years of research demonstrating its utility in a myriad of clinical applications (e.g. cancer\, neuroscience\, critical care\, metabolic disease\, etc.)\, time-dependent methods are complex\, bulky\, and expensive. This has resulted\, at best\, in slowed clinical adoption and\, at worst\, distrust of the technology itself. In order to overcome these barriers\, our group researches new optical components and techniques for diffuse optical spectroscopy that are leading to a new generation of handheld\, wearable\, and even implantable systems.  This will facilitate the conversion of advanced time-dependent imaging methods to accessible compact systems that will drive widespread use in biomedical sensing and imaging. \nBiography\nDr. Thomas O’Sullivan has been an assistant professor in the Department of Electrical Engineering at the University of Notre Dame since 2016. Prior to that he was Director of the Diffuse Optical Spectroscopy and Imaging Laboratory at the Beckman Laser Institute of the University of California\, Irvine and a U.S. Department of Defense Breast Cancer Research Program Postdoctoral Fellow. He received the B.S. degree in Electrical Engineering from Northwestern University in 2005 and the M.S. and Ph.D. in Electrical Engineering from Stanford University in 2007 and 2011\, respectively. Dr. O’Sullivan is engaged in translational biomedical research based upon the development and application of deep tissue optical imaging and sensing. In addition to his research\, Dr. O’Sullivan is passionate about community outreach\, has served the optics and photonics community through multiple volunteer roles for OSA and SPIE\, and is currently an associate editor for Biomedical Optics Express.  \nFor more information or to schedule a meeting with the speaker\, please contact Hanna Kim.
URL:https://bli.uci.edu/event/thomas-osullivan-phd/
LOCATION:3201 Natural Sciences II
ATTACH;FMTTYPE=image/jpeg:https://bli.uci.edu/wp-content/uploads/2019/07/Thomas-OSullivan-192.jpg
END:VEVENT
END:VCALENDAR